Low density lipoproteins inhibit the Na+/H+ antiport in human platelets via activation of p38MAP kinase

Biochemical and Biophysical Research Communications

Volumn 340, Issue 3, 2006, Pages 751-757

  Nofer, Jerzy Roch ^a,b   Noll, Christian ^c   Feuerborn, Renata ^b   Assmann, Gerd ^a,b   Tepel, Martin ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Low density lipoproteins; Na+ H + antiport; p38MAP kinase; Platelets

Indexed keywords

6 (4 FLUOROPHENYL) 2,3 DIHYDRO 5 (4 PYRIDYL)IMIDAZO[2,1 B]THIAZOLE; HEAT SHOCK PROTEIN 27; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OLIGOPEPTIDE; SODIUM PROTON EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1;

AMINO ACID SEQUENCE; ARTICLE; CELL PH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; THROMBOCYTE; THROMBOCYTE ACTIVATION;

BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; HYDROGEN PEROXIDE; IMIDAZOLES; LIPOPROTEINS, LDL; MAP KINASE KINASE 3; MAP KINASE KINASE 6; MAP KINASE SIGNALING SYSTEM; OLIGOPEPTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; PHOSPHORYLATION; PROPIONIC ACIDS; SODIUM-HYDROGEN ANTIPORTER; THIAZOLES; THROMBIN; TIME FACTORS;

EID: 30144444069     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.12.070     Document Type: Article

References (21)

1. P.O. Kviterovich Jr. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity Am. J. Cardiol. 90 2002 30i 47i
2. I.A. Relou, C.M. Hackeng, J.W. Akkerman, and E. Malle Low-density lipoprotein and its effect on human blood platelets Cell Mol. Life. Sci. 60 2003 961 971
3. G. van Willigen, G. Gorter, and J.W. Akkerman LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules Arterioscler. Thromb. 14 1994 41 46
4. A. Weidtmann, R. Scheithe, N. Hrboticky, A. Pietsch, R. Lorenz, and W. Siess Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2 Arterioscler. Thromb. Vasc. Biol. 15 1995 1131 1138
5. C.M. Hackeng, M. Huigsloot, M.W. Pladet, H.K. Nieuwenhuis, H.J. van Rijn, and J.W. Akkerman Low-density lipoprotein enhances platelet secretion via integrin-alphaIIbbeta3-mediated signaling Arterioscler. Thromb. Vasc. Biol. 19 1999 239 247
6. J.R. Nofer, M. Tepel, B. Kehrel, S. Wierwille, M. Walter, U. Seedorf, W. Zidek, and G. Assmann Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia Circulation 95 1997 1370 1377
7. C.M. Hackeng, I.A. Relou, M.W. Pladet, G. Gorter, H.J. van Rijn, and J.W. Akkerman Early platelet activation by low density lipoprotein via p38MAP kinase Thromb. Haemost. 82 1999 1749 1756
8. A.M. Relou, G. Gorter, H.J. van Rijn, and J.W. Akkerman Platelet activation by the apoB/E receptor-binding domain of LDL Thromb. Haemost. 87 2002 880 887
9. C.M. Hackeng, B. Franke, I.A. Relou, G. Gorter, J.L. Bos, H.J. van Rijn, and J.W. Akkerman Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets Biochem. J. 349 2000 231 238
10. + antiport in human platelets Thromb. Haemost. 75 1996 635 641
11. J.R. Nofer, E. Pulawski, R. Junker, U. Seedorf, G. Assmann, W. Zidek, and M. Tepel Na(+)/Ca(2+) exchange inhibitors modulate thapsigargin-induced Ca(2+) and Na(+) influx in human lymphocytes Int. J. Clin. Lab. Res. 29 1999 89 92
12. + exchange and ERK1/2 Circ. Res. 83 1998 824 831
13. J.R. Nofer, M. Walter, B. Kehrel, S. Wierwille, M. Tepel, U. Seedorf, and G. Assmann HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide- derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate Arterioscler. Thromb. Vasc. Biol. 18 1998 861 869
14. L. Coulon, C. Calzada, P. Moulin, E. Vericel, and M. Lagarde Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets Free Radic. Biol. Med. 35 2003 616 625
15. S.J. Korporaal, I.A. Relou, H.J. van Rijn, and J.W. Akkerman Lysophosphatidic acid-independent platelet activation by low-density lipoprotein FEBS Lett. 494 2001 121 124
16. K.K. Griendling, D. Sorescu, B. Lassegue, and M. Ushio-Fukai Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology Arterioscler. Thromb. Vasc. Biol. 20 2000 2175 2183
17. 2 in vascular smooth muscle cells: potential involvement in vascular disease Int. J. Mol. Med. 11 2003 229 234
18. + exchanger (NHE) NHE isoform 1 in human breast cancer cells Clin. Cancer Res. 9 2003 2366 2373
19. A.R. Khaled, A.N. Moor, A. Li, K. Kim, D.K. Ferris, K. Muegge, R.J. Fisher, L. Fliegel, and S.K. Durum Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization Mol. Cell. Biol. 21 2001 7545 7557
20. R. Polanowska-Grabowska, and A.R. Gear Heat-shock proteins and platelet function Platelets 11 2000 6 22
21. E. Butt, D. Immler, H.E. Meyer, A. Kotlyarov, K. Laass, and M. Gaestel Heat shock protein 27 is a substrate of cGMP-dependent protein kinase in intact human platelets: phosphorylation-induced actin polymerization caused by HSP27 mutants J. Biol. Chem. 276 2001 7108 7113